Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in SMMT — Summit Therapeutics Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$3,487,285
-$1,021,175 QoQ
Shares Held
239,347
+0.7% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 242 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. SMMT ranks #84 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in SMMT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,487,285 239,347
2026-03-31 $4,508,460 237,788
2025-12-31 $4,158,912 237,788
2025-09-30 $5,575,803 269,884
2025-06-30 $5,698,528 267,788
2025-03-31 $8,248,769 427,619
2024-12-31 $8,544,328 478,808
2024-09-30 $8,709,148 397,678
2024-06-30 $372,004 47,693
2024-03-31 $296,117 71,526
2023-12-31 $191,147 73,237
2023-09-30 $122,203 65,350
2023-06-30 $134,670 53,654
2022-03-31 $35,059 14,310
2021-12-31 $43,061 16,008
2021-09-30 $75,941 15,158
2021-06-30 $99,613 13,353
2021-03-31 $52 9